Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 33 Leukemia, Lymphocytic, Chronic, B-Cell 31 Lymphoma, Mantle-Cell 26 Waldenstrom Macroglobulinemia 18 Lymphoma, Follicular 18 Lymphoma, B-Cell, Marginal Zone 16 Recurrence 13 Lymphoma 12 Lymphoma, B-Cell 9 Lymphoma, Non-Hodgkin 6 Leukemia 4 B-cell Malignancies 3 Neoplasms 2 Hematologic Neoplasms 2 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mature B-Cell Malignancies 1 Lymphoma, T-Cell 1 Lymphohistiocytosis, Hemophagocytic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, B-Cell 1 Intraocular Lymphoma 1 Hematologic Diseases 1 Dendritic Cell Sarcoma, Interdigitating 1 Congenital Abnormalities 1 Cardiovascular Diseases 1

Interventions

Rituximab 17 Peripheral Blood Stem Cell Transplantation 15 Cyclophosphamide 15 fludarabine phosphate 12 Whole-Body Irradiation 11 Cyclosporine 10 Mycophenolic Acid 9 Etoposide 9 Methotrexate 8 Filgrastim 8 Lenalidomide 7 Tacrolimus 6 Dexamethasone 6 Busulfan 6 Radiotherapy 5 Melphalan 5 Cytarabine 5 Carboplatin 5 Vorinostat 4 Thiotepa 4 Therapeutics 4 Psychiatric Rehabilitation 4 Bortezomib 4 Antilymphocyte Serum 4 Transplantation 3 Methylprednisolone 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Flow Cytometry 3 Dasatinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Intraocular Lymphoma × zanubrutinib × Clear all

NCT06973811 2025-05-20

ZR-MTX

Peking Union Medical College Hospital

Phase 2 Not yet recruiting

Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡